Scarica l'app Stockscreener
28.79
10.87%
-3.51
Pre-mercato:
28.21
-0.58
-2.01%
Apogee Therapeutics Inc Azioni (APGE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-09-30 |
| Durata del periodo | 3 mesi | 3 mesi |
| Revenues |
-
|
- |
Operating Expenses
|
57.09%
38.18
|
24.30 |
| Operating Income/Loss |
57.09%
-38.18
|
-24.30 |
| Income/Loss From Continuing Operations Before Tax |
54.00%
-32.09
|
-20.84 |
| Income/Loss From Continuing Operations After Tax |
54.00%
-32.09
|
-20.84 |
|
Net Income/Loss
|
54.00%
-32.09
|
-20.84 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- |
| Attributable To Noncontrolling Interest |
-
|
- |
| Basic Average Shares |
21.73%
50.19
|
41.23 |
| Diluted Average Shares |
21.73%
50.19
|
41.23 |
| Basic Earnings Per Share |
25.49%
-0.64
|
-0.51 |
| Diluted Earnings Per Share |
25.49%
-0.64
|
-0.51 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):